Siegfried Reich, EVP & Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 61,580 shares at $107.85 ($6.5M) on 2021-03-04, disclosed to the SEC on 2021-03-05.
Open-market sale of $6.5M TPTX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.01 | 3,005 | $307K | 4.7% |
| 2 | $102.01 | 3,005 | $307K | 4.7% |
| 3 | $102.87 | 8,820 | $907K | 14.0% |
| 4 | $102.87 | 8,820 | $907K | 14.0% |
| 5 | $103.65 | 6,220 | $645K | 10.0% |
| 6 | $104.97 | 2,000 |
| $210K |
| 3.2% |
| 7 | $105.71 | 3,103 | $328K | 5.1% |
| 8 | $105.71 | 3,103 | $328K | 5.1% |
| 9 | $107.13 | 6,716 | $719K | 11.1% |
| 10 | $107.13 | 6,716 | $719K | 11.1% |
| 11 | $107.85 | 3,679 | $397K | 6.1% |
| 12 | $107.85 | 3,679 | $397K | 6.1% |
| 13 | $108.92 | 707 | $77K | 1.2% |
| 14 | $108.92 | 707 | $77K | 1.2% |
| 15 | $110.59 | 700 | $77K | 1.2% |
| 16 | $111.46 | 600 | $67K | 1.0% |
| Total | $105.05 avg | 61,580 | $6.5M | 100% |
| Filing → |
| SGXP | SELL | 2008-07-16 | $2K | — | Filing → |
| SGXP | SELL | 2008-06-17 | $1K | — | Filing → |
| SGXP | SELL | 2008-05-15 | $1K | — | Filing → |